Accelerate your tech game Paid Content How the New Space Race Will Drive Innovation How the metaverse will change the future of work and society Managing the ...

The U.S. Mint is issuing special circulating coins to celebrate the 250th anniversary of American's adoption of the Declaration of Independence. Quarters, dimes and nickels minted during 2026 will ...

The U.S. Mint has unveiled coins designs for America's 250th independence anniversary next year, featuring classical depictions of founding documents and the Revolutionary War. Donald Trump is notably ...

There are several rare coins out there that could be worth much more than their face value thanks to unique designs or printing errors – and here are five of the rarest Finding one of these five coins ...

New coins will bring a change to your pocket change in 2026. The United States Mint is set to roll out five new quarters and a dime to mark the nation's 250th anniversary. Officials unveiled the coins ...

The next signs of the nation’s political divide might be jingling in your pocket next year. The administration plans to issue a $1 coin with President Donald Trump’s likeness on it next year, despite ...

Copyright 2025 The Associated Press. All Rights Reserved. Copyright 2025 The Associated Press. All Rights Reserved. Add AP News on Google Add AP News as your ...

FIRST ON FOX: Secretary of the Treasury Scott Bessent scrapped Biden-era coin designs intended to celebrate the 250th anniversary of America’s founding after the Trump administration discovered they ...

The United States will celebrate its 250th anniversary, or Semiquincentennial, in 2026 with a new set of circulating coins, created and released by the U.S. Mint, that celebrate the nation’s founding.

There are quite a few pretty Canadian coins in circulation right now. You could find colourful coins, like a red toonie, blue dime, green toonie and more, in your change. Each year, the Royal Canadian ...

Recursion Pharmaceuticals, Inc. remains a Sell as pipeline progress, notably REC-4881 in FAP, fails to surpass cheap alternatives like Celebrex. REC-4881's Phase 1/2 data show a median polyp reduction ...